FOLD logo

Amicus Therapeutics (FOLD) Interest Expense

Annual Interest Expense

$50.15 M
+$13.03 M+35.10%

December 31, 2023


Summary


Performance

FOLD Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFOLDexpensesmetrics:

Quarterly Interest Expense

$12.69 M
+$180.00 K+1.44%

September 30, 2024


Summary


Performance

FOLD Quarterly Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFOLDexpensesmetrics:

TTM Interest Expense

$50.47 M
-$294.00 K-0.58%

September 30, 2024


Summary


Performance

FOLD TTM Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFOLDexpensesmetrics:

Interest Expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

FOLD Interest Expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+35.1%-2.3%+4.2%
3 y3 years+123.6%-2.3%+4.2%
5 y5 years+123.9%-2.3%+4.2%

FOLD Interest Expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+54.4%-2.3%+55.8%-0.6%+55.4%
5 y5-yearat high+165.7%-2.3%+249.2%-0.6%+233.0%
alltimeall timeat high>+9999.0%-2.3%>+9999.0%-0.6%>+9999.0%

Amicus Therapeutics Interest Expense History

DateAnnualQuarterlyTTM
Sep 2024
-
$12.69 M(+1.4%)
$50.47 M(-0.6%)
Jun 2024
-
$12.51 M(+0.6%)
$50.76 M(+0.0%)
Mar 2024
-
$12.44 M(-3.0%)
$50.74 M(+1.2%)
Dec 2023
$50.15 M(+35.1%)
$12.83 M(-1.2%)
$50.15 M(+3.6%)
Sep 2023
-
$12.99 M(+4.0%)
$48.42 M(+7.5%)
Jun 2023
-
$12.49 M(+5.5%)
$45.05 M(+10.4%)
Mar 2023
-
$11.84 M(+6.8%)
$40.82 M(+10.0%)
Dec 2022
$37.12 M(+14.3%)
$11.10 M(+15.3%)
$37.12 M(+8.6%)
Sep 2022
-
$9.62 M(+16.5%)
$34.19 M(+4.4%)
Jun 2022
-
$8.26 M(+1.4%)
$32.73 M(+0.3%)
Mar 2022
-
$8.15 M(-0.2%)
$32.63 M(+0.5%)
Dec 2021
$32.47 M(+44.8%)
$8.16 M(-0.0%)
$32.47 M(-0.3%)
Sep 2021
-
$8.16 M(+0.2%)
$32.58 M(+4.4%)
Jun 2021
-
$8.15 M(+2.0%)
$31.20 M(+16.9%)
Mar 2021
-
$7.99 M(-3.4%)
$26.69 M(+19.0%)
Dec 2020
$22.43 M(+18.8%)
$8.28 M(+22.0%)
$22.43 M(+25.2%)
Sep 2020
-
$6.78 M(+86.6%)
$17.91 M(+18.2%)
Jun 2020
-
$3.63 M(-2.5%)
$15.16 M(-6.1%)
Mar 2020
-
$3.73 M(-1.0%)
$16.15 M(-14.4%)
Dec 2019
$18.87 M(-15.8%)
$3.77 M(-6.4%)
$18.87 M(-20.5%)
Sep 2019
-
$4.03 M(-13.0%)
$23.74 M(-2.8%)
Jun 2019
-
$4.63 M(-28.3%)
$24.43 M(+0.3%)
Mar 2019
-
$6.45 M(-25.3%)
$24.37 M(+8.8%)
Dec 2018
$22.40 M(+29.9%)
$8.64 M(+83.2%)
$22.40 M(+23.2%)
Sep 2018
-
$4.71 M(+3.4%)
$18.18 M(+2.0%)
Jun 2018
-
$4.56 M(+1.6%)
$17.82 M(+2.2%)
Mar 2018
-
$4.49 M(+1.5%)
$17.44 M(+1.1%)
Dec 2017
$17.24 M(+219.4%)
$4.42 M(+1.6%)
$17.24 M(+17.3%)
Sep 2017
-
$4.35 M(+4.1%)
$14.70 M(+23.9%)
Jun 2017
-
$4.18 M(-2.6%)
$11.87 M(+35.7%)
Mar 2017
-
$4.29 M(+128.1%)
$8.74 M(+62.0%)
Dec 2016
$5.40 M
$1.88 M(+24.0%)
$5.40 M(+23.6%)
DateAnnualQuarterlyTTM
Sep 2016
-
$1.52 M(+43.8%)
$4.37 M(+52.3%)
Jun 2016
-
$1.05 M(+11.6%)
$2.87 M(+33.3%)
Mar 2016
-
$945.00 K(+11.0%)
$2.15 M(+36.3%)
Dec 2015
$1.58 M(+6.3%)
$851.00 K(+4905.9%)
$1.58 M(+42.8%)
Sep 2015
-
$17.00 K(-95.0%)
$1.10 M(-24.6%)
Jun 2015
-
$338.00 K(-9.1%)
$1.47 M(-2.4%)
Mar 2015
-
$372.00 K(-1.6%)
$1.50 M(+1.1%)
Dec 2014
$1.48 M(+3126.1%)
$378.00 K(+0.3%)
$1.48 M(+31.8%)
Sep 2014
-
$377.00 K(+0.8%)
$1.13 M(+48.9%)
Jun 2014
-
$374.00 K(+5.4%)
$756.00 K(+93.4%)
Mar 2014
-
$355.00 K(+1675.0%)
$391.00 K(+750.0%)
Dec 2013
$46.00 K(-48.3%)
$20.00 K(+185.7%)
$46.00 K(+21.1%)
Sep 2013
-
$7000.00(-22.2%)
$38.00 K(-24.0%)
Jun 2013
-
$9000.00(-10.0%)
$50.00 K(-10.7%)
Mar 2013
-
$10.00 K(-16.7%)
$56.00 K(-37.1%)
Dec 2012
$89.00 K(-39.9%)
$12.00 K(-36.8%)
$89.00 K(-14.4%)
Sep 2012
-
$19.00 K(+26.7%)
$104.00 K(-11.1%)
Jun 2012
-
$15.00 K(-65.1%)
$117.00 K(-18.2%)
Mar 2012
-
$43.00 K(+59.3%)
$143.00 K(-3.4%)
Dec 2011
$148.00 K(-43.1%)
$27.00 K(-15.6%)
$148.00 K(-16.9%)
Sep 2011
-
$32.00 K(-22.0%)
$178.00 K(-16.0%)
Jun 2011
-
$41.00 K(-14.6%)
$212.00 K(-6.2%)
Mar 2011
-
$48.00 K(-15.8%)
$226.00 K(-13.4%)
Dec 2010
$260.00 K(-6.5%)
$57.00 K(-13.6%)
$261.00 K(-20.2%)
Sep 2010
-
$66.00 K(+20.0%)
$327.00 K(-5.2%)
Jun 2010
-
$55.00 K(-33.7%)
$345.00 K(+4.2%)
Mar 2010
-
$83.00 K(-32.5%)
$331.00 K(+19.5%)
Dec 2009
$278.00 K(+27.5%)
$123.00 K(+46.4%)
$277.00 K(+79.9%)
Sep 2009
-
$84.00 K(+104.9%)
$154.00 K(+120.0%)
Jun 2009
-
$41.00 K(+41.4%)
$70.00 K(+141.4%)
Mar 2009
-
$29.00 K
$29.00 K
Dec 2008
$218.00 K
-
-

FAQ

  • What is Amicus Therapeutics annual interest expense?
  • What is the all time high annual interest expense for Amicus Therapeutics?
  • What is Amicus Therapeutics annual interest expense year-on-year change?
  • What is Amicus Therapeutics quarterly interest expense?
  • What is the all time high quarterly interest expense for Amicus Therapeutics?
  • What is Amicus Therapeutics quarterly interest expense year-on-year change?
  • What is Amicus Therapeutics TTM interest expense?
  • What is the all time high TTM interest expense for Amicus Therapeutics?
  • What is Amicus Therapeutics TTM interest expense year-on-year change?

What is Amicus Therapeutics annual interest expense?

The current annual interest expense of FOLD is $50.15 M

What is the all time high annual interest expense for Amicus Therapeutics?

Amicus Therapeutics all-time high annual interest expense is $50.15 M

What is Amicus Therapeutics annual interest expense year-on-year change?

Over the past year, FOLD annual interest expense has changed by +$13.03 M (+35.10%)

What is Amicus Therapeutics quarterly interest expense?

The current quarterly interest expense of FOLD is $12.69 M

What is the all time high quarterly interest expense for Amicus Therapeutics?

Amicus Therapeutics all-time high quarterly interest expense is $12.99 M

What is Amicus Therapeutics quarterly interest expense year-on-year change?

Over the past year, FOLD quarterly interest expense has changed by -$294.00 K (-2.26%)

What is Amicus Therapeutics TTM interest expense?

The current TTM interest expense of FOLD is $50.47 M

What is the all time high TTM interest expense for Amicus Therapeutics?

Amicus Therapeutics all-time high TTM interest expense is $50.76 M

What is Amicus Therapeutics TTM interest expense year-on-year change?

Over the past year, FOLD TTM interest expense has changed by +$2.05 M (+4.23%)